Akèy › Leksemi mieloïd egi › Iowa › Cedar Rapids
Etid klinik pou Leksemi mieloïd egi nan Cedar Rapids, IA
16 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote Cedar Rapids (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Ap rekriteFaz 3
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Ap rekriteFaz 1/2
- University of Iowa Hospital, Iowa City · 25 mi lwen
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Ap rekriteEtid obsèvasyon
- University of Iowa Hospital and Clinics, Iowa City · 25 mi lwen
High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
Ap rekriteFaz 1
- University of Iowa Health Care, Iowa City · 25 mi lwen
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Ap rekriteFaz 1/2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi lwen
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Ap rekriteFaz 3
- University of Iowa Stead Family Children's Hospital, Iowa City · 25 mi lwen
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Ap rekriteFaz 3
- University of Iowa, Iowa City · 25 mi lwen
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
- University of Iowa Hospitals & Clinics, Iowa City · 25 mi lwen
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Ap rekriteFaz 3
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi lwen
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- University of Iowa, Iowa City · 25 mi lwen
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Ap rekriteFaz 1
- University of Iowa Hospitals & Clinics, Iowa City · 25 mi lwen
Etid Leksemi mieloïd egi nan lòt vil
- Houston, TX85 etid
- New York City, NY51 etid
- Boston, MA44 etid
- Baldwin Park, CA40 etid
- Seattle, WA40 etid
- Columbus, OH35 etid
- Philadelphia, PA34 etid
- Durham, NC33 etid
- Atlanta, GA30 etid
- Tampa, FL29 etid
- Chicago, IL26 etid
- Portland, OR25 etid
Lòt etid nan Cedar Rapids
- Kansè Poumon ki pa ti selil20 etid
- Kansè nan tete17 etid
- Kansè (tout kalite)15 etid
- Myelom Miltip15 etid
- Kansè poumon14 etid
- Kansè kolorektal13 etid
- Kansè pwostat12 etid
- Karsinòm selil skuamèz tèt ak kou12 etid
- Melanom10 etid
- Akidan serebavaskilè10 etid
- Kansè Metastatik9 etid
- Kansè Endomèt9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.